Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 89
Filter
Add more filters

Country/Region as subject
Affiliation country
Publication year range
1.
BMC Neurol ; 24(1): 72, 2024 Feb 20.
Article in English | MEDLINE | ID: mdl-38378548

ABSTRACT

OBJECTIVE: Our research aims to elucidate the significance of type 2 diabetes (T2D) and provides an insight into a novel risk model for post-cerebral infarction cognitive dysfunction (PCICD). METHODS: Our study recruited inpatients hospitalized with cerebral infarction in Xijing hospital, who underwent cognitive assessment of Mini-Mental State Examination (MMSE) from January 2010 to December 2021. Cognitive status was dichotomized into normal cognition and cognitive impairment. Collected data referred to Demographic Features, Clinical Diseases, scale tests, fluid biomarkers involving inflammation, coagulation function, hepatorenal function, lipid and glycemic management. RESULTS: In our pooled dataset from 924 eligible patients, we included 353 in the final analysis (age range 65-91; 30.31% female). Multivariate logistic regression analysis was performed to show that Rural Areas (OR = 1.976, 95%CI = 1.111-3.515, P = 0.020), T2D (OR = 2.125, 95%CI = 1.267-3.563, P = 0.004), Direct Bilirubin (OR = 0.388, 95%CI = 0.196-0.769, P = 0.007), Severity of Dependence in terms of Barthel Index (OR = 1.708, 95%CI = 1.193-2.445, P = 0.003) that were independently associated with PCICD, constituting a model with optimal predictive efficiency. CONCLUSION: To the best of our knowledge, this study provides a practicable map of strategical predictors to robustly identify cognitive dysfunction at risk of post-cerebral infarction for clinicians in a broad sense. Of note, our findings support that the decline in serum direct bilirubin (DBil) concentration is linked to protecting cognitive function.


Subject(s)
Cognitive Dysfunction , Diabetes Mellitus, Type 2 , Humans , Female , Aged , Aged, 80 and over , Male , Retrospective Studies , Diabetes Mellitus, Type 2/complications , Cognitive Dysfunction/etiology , Cognitive Dysfunction/complications , Risk Factors , Cerebral Infarction/complications , Cerebral Infarction/epidemiology , Cognition , Bilirubin
2.
Network ; : 1-22, 2024 Jun 11.
Article in English | MEDLINE | ID: mdl-38860469

ABSTRACT

Railway Point Machine (RPM) is a fundamental component of railway infrastructure and plays a crucial role in ensuring the safe operation of trains. Its primary function is to divert trains from one track to another, enabling connections between different lines and facilitating route selection. By judiciously deploying turnouts, railway systems can provide efficient transportation services while ensuring the safety of passengers and cargo. As signal processing technologies develop rapidly, taking the easy acquisition advantages of audio signals, a fault diagnosis method for RPMs is proposed by considering noise and multi-channel signals. The proposed method consists of several stages. Initially, the signal is subjected to pre-processing steps, including cropping and channel separation. Subsequently, the signal undergoes noise addition using the Random Length and Dynamic Position Noises Superposition (RDS) module, followed by conversion to a greyscale image. To enhance the data, Synthetic Minority Oversampling Technique (SMOTE) module is applied. Finally, the training data is fed into a Dual-input Attention Convolutional Neural Network (DIACNN). By employing various experimental techniques and designing diverse datasets, our proposed method demonstrates excellent robustness and achieves an outstanding classification accuracy of 99.73%.

3.
Article in English | MEDLINE | ID: mdl-39004184

ABSTRACT

OBJECTIVE: To compare oncologic outcomes after laparoscopic or laparotomic surgery to treat epithelial ovarian carcinoma in FIGO stage I. DESIGN: Retrospective cohort study. SETTING: Gynecological cancer ward in a tertiary hospital. PARTICIPANTS: A total of 85 patients with FIGO stage I epithelial ovarian carcinoma who underwent laparoscopic staging surgery and 206 who underwent laparotomic staging surgery at West China Second Hospital, Sichuan University (Chengdu, China) between January 1, 2013 and December 31, 2019. INTERVENTIONS: laparoscopic surgery or laparotomic staging surgery. RESULTS: Before propensity score-based matching, the laparotomy group showed higher prevalence of preoperative elevated CA125 level (48.5% vs 35.3%, p = .045) and tumors > 15 cm (27.2% vs 5.9%, p < .001). Multivariate analysis associated higher body mass index with better overall survival (adjusted HR 0.83, 95%CI 0.70-0.99, p = .043). Among propensity score-matched patients (82 per group) who were matched to each other according to propensity scoring based on age, body mass index, CA125 level, largest tumor diameter, FIGO stage, history of abdominal surgery, and American Society of Anesthesiologists grade, the rate of progression-free survival at 5 years was similar between the laparoscopy group (87.1%, 95%CI 79.3-95.7%) and the laparotomy group (90.9%, 95%CI 84.7-97.6%, p = .524), as was the rate of overall survival at 5 years (93.9%, 95%CI 88.0-100.0% vs 94.7%, 95%CI 89.8-99.9%, p = .900). Regardless of whether patients were matched, the two groups showed similar rates of recurrence of 9-11% during follow-up lasting a median of 54.9 months. CONCLUSIONS: Rates of recurrence and survival may be similar between laparoscopy or laparotomy to treat stage I epithelial ovarian cancer. Since laparoscopy is associated with less bleeding and faster recovery, it may be a safe, effective alternative to laparotomy for appropriate patients.

4.
BMC Cancer ; 23(1): 31, 2023 Jan 09.
Article in English | MEDLINE | ID: mdl-36624407

ABSTRACT

OBJECTIVE: To compare recurrence and survival in patients with stage III endometrial cancer after radical surgery, followed by either adjuvant chemoradiotherapy (ACR) or adjuvant chemotherapy (AC). METHODS: We searched for relevant studies in PubMed Central, Embase and the Cochrane Central Register of Controlled Trials. Data were pooled on rates of recurrence as well as rates of progression-free, disease-free and overall survival. Heterogeneity was evaluated using the I2 test. Subgroup and sensitivity analyses were performed to identify potential sources of heterogeneity. RESULTS: Data from 18,375 patients in 15 retrospective studies and one randomized controlled trial were meta-analyzed. Compared to the AC group, the ACR showed significantly lower risk of local recurrence (OR 0.43, 95%CI 0.32-0.59) and total recurrence (OR 0.72, 95%CI 0.58-0.89). ACR was also associated with significantly better overall survival (HR 0.66, 95%CI 0.57-0.76), progression-free survival (HR 0.56, 95%CI 0.39-0.81) and disease-free survival (HR 0.66, 95%CI 0.53-0.83). CONCLUSIONS: Adding adjuvant radiotherapy to adjuvant chemotherapy after radical surgery may significantly reduce risk of local and overall recurrence, while significantly improving survival of patients with stage III endometrial cancer.


Subject(s)
Endometrial Neoplasms , Female , Humans , Retrospective Studies , Neoplasm Staging , Endometrial Neoplasms/surgery , Endometrial Neoplasms/drug therapy , Chemotherapy, Adjuvant , Chemoradiotherapy, Adjuvant , Chemoradiotherapy , Radiotherapy, Adjuvant
5.
J Obstet Gynaecol Res ; 49(8): 2199-2204, 2023 Aug.
Article in English | MEDLINE | ID: mdl-37199068

ABSTRACT

Symptoms of pelvic masses, elevated serum CA125 levels, massive ascites, and pleural effusion in female patients are usually associated with malignancy. Some benign ovarian tumors or other nonmalignant tumors may also produce similar symptoms, called Meigs syndrome or pseudo-Meigs' syndrome, which should be one of the differential diagnoses. However, there is an extremely rare form of SLE called pseudo-pseudo Meigs syndrome (PPMS), which may also present with the above symptoms, but is not associated with any of the tumors. In this paper, we report a case of a 47-year-old woman who presented with abdominal distention. The patient was found to have elevated serum CA125 levels to 182.9 U/mL before the operation. Her PET-CT suggested a large heterogeneous mass in the pelvis measuring 8.2 × 5.8 cm with a large amount of ascites. She was initially diagnosed with ovarian cancer and underwent exploratory laparotomy. Pathology of the surgical specimen revealed a uterine leiomyoma. Two months after discharge, the patient's ascites reappeared along with recurrent intestinal obstruction. After ascites and serological tests, she was eventually diagnosed with systemic lupus erythematosus and received systemic hormonal therapy.


Subject(s)
Abdominal Neoplasms , Lupus Erythematosus, Systemic , Meigs Syndrome , Humans , Female , Middle Aged , Meigs Syndrome/diagnosis , Meigs Syndrome/pathology , Meigs Syndrome/surgery , Ascites/diagnosis , Ascites/etiology , Positron Emission Tomography Computed Tomography , Lupus Erythematosus, Systemic/complications , Lupus Erythematosus, Systemic/diagnosis , Diagnostic Errors/adverse effects
6.
Sensors (Basel) ; 23(7)2023 Mar 31.
Article in English | MEDLINE | ID: mdl-37050709

ABSTRACT

Fiber-optic refractive index (RI) sensors based on wavelength-shift-based interrogation continue to present a challenge in achieving high sensitivity for a wide detection range. In this paper, we propose a sensor for determining the RI of liquids based on femtosecond laser (fs-laser) writing of a dual-side polished singlemode-multimode-singlemode (SMS) fiber. The proposed sensor can determine the RI value of a surrounding liquid by detecting the dip wavelength in the transmission spectrum of the light propagating through the sensing area. The high RI sensitivity is attributed to the increased interaction area established by the fs-laser, which creates hydrophilic surfaces and maintains the wide detection range of the SMS structure. The results of the wavelength-shift-based interrogation reveal that the fabricated device exhibited a high sensitivity of 161.40 nm per refractive index unit (RIU) over a wide RI detection range of 0.062 RIU. The proposed device has high processing accuracy and a simple manufacturing process. Hence, it has the potential to be used as a lab-on-fiber sensing platform in chemical and biotechnological applications.

7.
J Child Sex Abus ; 32(2): 225-240, 2023 Feb.
Article in English | MEDLINE | ID: mdl-36705088

ABSTRACT

Parents play a key role in child CSA prevention, but the mechanisms underlying the intergenerational knowledge transmission are not fully understood. This study explores the role of two parenting practices - parent-child communication and parent's protective behavior - as mediating factors in the relation between parents' knowledge and their children's knowledge and skills. Four hundred and ten dyads of early adolescents and their mother or father from rural China participated in the study. Parents were surveyed on their knowledge, protective behaviors, and parent-child communication regarding CSA, while children answered questions on relevant knowledge and skills. Results revealed that parental knowledge was positively and significantly related to communication and protective behavior, protective behavior was positively related to children's knowledge and skills, but the coefficient between communication and children's knowledge and skills was insignificant. The findings highlight direct parental protection as one of the most important mechanism for intergenerational knowledge transmission.


Subject(s)
Child Abuse, Sexual , Female , Adolescent , Child , Humans , Child Abuse, Sexual/prevention & control , Parents , Parent-Child Relations , China , Communication , Parenting
8.
Bioorg Chem ; 127: 105939, 2022 10.
Article in English | MEDLINE | ID: mdl-35700569

ABSTRACT

Thirty-three novel paeonol etherized aryl urea derivatives (PEUs) were synthesized via a bromination-Williamson Ether Synthesis-deprotection-nucleophilic addition reaction sequence. The structures of PEUs were characterized by LC-MS, HRMS, 1H NMR and 13C NMR spectra. The levels of nitric oxide (NO), tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1ß) in lipopolysaccharide (LPS)-induced RAW264.7 macrophages were initially employed to evaluate the anti-inflammatory effects of all compounds. Remarkably, b16 exhibited a good anti-inflammatory activity at 2.5 µm which is the same as the potency of paeonol at 20 µm. The results of mechanism research displayed that the anti-inflammatory effect of b16 was ascribed to the inhibition of the TLR4/MyD88 signaling pathway and inflammatory factors. Additionally, b16 distinctly reduced the generation of free radicals in macrophages and strikingly increased the mitochondrial membrane potential. According to the structure-activity relationships (SAR) of PEUs, the incorporation of halogens on the benzene ring and the hydrogen of phenol hydroxyl substituted by aryl urea, were beneficial to enhance the anti-inflammatory activities. Molecular docking results illustrated that the binding ability of b16 to TLR4 was stronger than that of paeonol. In summary, the novel aryl urea-derivied paeonol b16 could be a new promising candidate for the treatment of inflammation-related diseases.


Subject(s)
Myeloid Differentiation Factor 88 , Toll-Like Receptor 4 , Acetophenones , Animals , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/pharmacology , Lipopolysaccharides/pharmacology , Mice , Molecular Docking Simulation , Myeloid Differentiation Factor 88/metabolism , Myeloid Differentiation Factor 88/pharmacology , RAW 264.7 Cells , Signal Transduction , Toll-Like Receptor 4/metabolism , Urea/pharmacology
9.
Sichuan Da Xue Xue Bao Yi Xue Ban ; 53(6): 1118-1126, 2022 Nov.
Article in Zh | MEDLINE | ID: mdl-36443062

ABSTRACT

N 6-methyladenosine (m 6A) is the most prevalent post-transcriptional RNA modification in eukaryotic cells. m 6A methyltransferase complexes and demethylases are involved in the dynamic and reversible regulation of m 6A modification, while m 6A binding proteins could specifically identify m 6A modification and regulate RNA metabolism, including splicing, translocation, stability, and translation. m 6A is found to play a vital role in all the fundamental biological processes, including the regulation of the immune system, from normal development to diseases. The normal development and functioning of the immune system rely on the precise regulation of the relevant gene expression, and m 6A modification is crucial to the regulation. Herein, we reviewed the concept, the functions, and the mechanism of m 6A modification, concentrating on its role in immune system function modulation. Furthermore, we highlighted present obstacles and future research directions in the field, intending to provide a theoretical foundation and reference for future study on how m 6A modification is involved in immune regulation.


Subject(s)
Immunity , RNA , Cytoplasm , Immunity/genetics
10.
Gynecol Oncol ; 162(3): 797-803, 2021 09.
Article in English | MEDLINE | ID: mdl-34119365

ABSTRACT

OBJECTIVE: Borderline ovarian tumors (BOTs) account for about 15% of all epithelial tumors of the ovary, and around 75% of patients are diagnosed in early stages. Although many of these patients have lymph node involvement (LNI), whether LNI decreases their survival is controversial, raising the question of whether lymphadenectomy should be performed. We conducted a systematic review and meta-analysis of these questions. METHODS: We searched articles related to LNI and lymphadenectomy in patients with BOTs in PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials. Data on rate of LNI, recurrence and survival were pooled and meta-analyzed using a random-effects model. Heterogeneity was evaluated using the I2 test. RESULTS: A total of 25 studies with 12,503 patients were meta-analyzed. The overall pooled rate of LNI was 10% [95% confidence interval (CI) 0.07-0.13]. LNI was associated with a higher risk of recurrence [odds ratio (OR) 2.23, 95% CI 1.13-4.40]. However, LNI did not significantly affect cause-specific survival [hazard ratio (HR) 1.73, 95% CI 0.99-3.02] or disease-free survival (HR 1.48, 95% CI 0.56-3.92). Similarly, lymphadenectomy did not significantly affect risk of recurrence (OR 0.91, 95% CI 0.57-1.46), overall survival (HR 0.90, 95% CI 0.58-1.40), disease-free survival (HR 0.95, 95% CI 0.61-1.50) or progression-free survival (HR 0.60, 95% CI 0.24-1.49). CONCLUSIONS: LNI appears to increase risk of recurrence in BOT patients, but neither it nor lymphadenectomy appears to influence prognosis. Therefore, lymphadenectomy should be considered only for certain BOT patients, such as those with suspected LNI based on imaging or surgical exploration.


Subject(s)
Carcinoma, Ovarian Epithelial/surgery , Lymph Node Excision/adverse effects , Ovarian Neoplasms/surgery , Carcinoma, Ovarian Epithelial/mortality , Female , Humans , Lymphatic Metastasis , Ovarian Neoplasms/mortality
11.
Int J Mol Sci ; 22(18)2021 Sep 13.
Article in English | MEDLINE | ID: mdl-34576057

ABSTRACT

Stomatal regulation is crucial to reduce water consumption under drought conditions. Extracellular ATP (eATP) serves as a signaling agent in stomatal regulation; however, it is less known whether the eATP mediation of stomatal aperture is linked to apyrases (APYs), the principal enzymes that control the concentration of eATP. To clarify the role of APYs in stomatal control, PeAPY1 and PeAPY2 were isolated from Populus euphratica and transferred into Arabidopsis. Compared with the wild-type Arabidopsis and loss-of-function mutants (Atapy1 and Atapy2), PeAPY1- and PeAPY2-transgenic plants decreased stomatal aperture under mannitol treatment (200 mM, 2 h) and reduced water loss during air exposure (90 min). The role of apyrase in stomatal regulation resulted from its control in eATP-regulated stomatal movements and increased stomatal sensitivity to ABA. The bi-phasic dose-responses to applied nucleotides, i.e., the low ATP (0.3-1.0 mM)-promoted opening and high ATP (>2.0 mM)-promoted closure, were both restricted by P. euphratica apyrases. It is noteworthy that eATP at a low concentration (0.3 mM) counteracted ABA action in the regulation of stomatal aperture, while overexpression of PeAPY1 or PeAPY2 effectively diminished eATP promotion in opening, and consequently enhanced ABA action in closure. We postulate a speculative model of apyrase signaling in eATP- and ABA-regulated stomatal movements under drought.


Subject(s)
Apyrase/genetics , Arabidopsis/genetics , Plants, Genetically Modified/genetics , Populus/enzymology , Arabidopsis/growth & development , Droughts , Gene Expression Regulation, Plant/genetics , Plant Stomata/genetics , Plants, Genetically Modified/growth & development , Populus/genetics , Stress, Physiological/genetics
12.
Acta Pharmacol Sin ; 41(9): 1223-1233, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32242118

ABSTRACT

Receptor-interacting protein 1 (RIP1, also known as RIPK1) is not only a tumor-promoting factor in several cancers but also mediates either apoptosis or necroptosis in certain circumstances. In this study we investigated what role RIP1 plays in human ovarian cancer cells. We showed that knockout (KO) of RIP1 substantially suppressed cell proliferation, accompanied by the G2/M checkpoint arrest in two human ovarian cancer cell lines SKOV3 and A2780. On the other hand, RIP1 KO remarkably attenuated cisplatin-induced cytotoxicity, which was associated with reduction of the apoptosis markers PARP cleavage and the necroptosis marker phospho-MLKL. We found that RIP1 KO suppressed cisplatin-induced ROS accumulation in both SKOV3 and A2780 cells. ROS scavenger BHA, apoptosis inhibitor Z-VAD or necroptosis inhibitor NSA could effectively suppress cisplatin's cytotoxicity in the control cells, suggesting that ROS-mediated apoptosis and necroptosis were involved in cisplatin-induced cell death. In addition, blocking necroptosis with MLKL siRNA effectively attenuated cisplatin-induced cytotoxicity. In human ovarian cancer A2780 cell line xenograft nude mice, RIP1 KO not only significantly suppressed the tumor growth but also greatly attenuated cisplatin's anticancer activity. Our results demonstrate a dual role of RIP1 in human ovarian cancer: it acts as either a tumor-promoting factor to promote cancer cell proliferation or a tumor-suppressing factor to facilitate anticancer effects of chemotherapeutics such as cisplatin.


Subject(s)
Apoptosis/physiology , Cell Proliferation/physiology , G2 Phase Cell Cycle Checkpoints/physiology , Necroptosis/physiology , Ovarian Neoplasms/metabolism , Receptor-Interacting Protein Serine-Threonine Kinases/deficiency , Animals , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Cell Line, Tumor , Cisplatin/pharmacology , Female , Gene Knockout Techniques , Humans , Mice, Inbred BALB C , Mice, Nude , Necroptosis/drug effects , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/genetics , Paclitaxel/pharmacology , Reactive Oxygen Species/metabolism , Receptor-Interacting Protein Serine-Threonine Kinases/genetics
13.
Sensors (Basel) ; 20(10)2020 May 15.
Article in English | MEDLINE | ID: mdl-32429034

ABSTRACT

The objective of this study is to evaluate and improve the accuracy and stability of a strain measurement method that uses the speeded-up robust feature (SURF) method to trace the displacement of feature points in microimages and obtain the strain in objects. The microimages were acquired using a smartphone with a portable microscope, which has a broad prospect of application. An experiment was performed using an unpacked optical fiber as the experimental carrier. The matching effect of the SURF method was analyzed in the microimage, and the M-estimator sample consensus (MSAC) algorithm was used to reject outliers generated by SURF. The results indicated that the accuracy of strain measurement using the proposed method is improved by modifying the feature point tracking method and measurement method. When compared with the fiber Bragg grating (FBG) data, the maximum standard error corresponded to 2.5 µÎµ, which satisfies the requirement of structural health monitoring (SHM) in practical engineering.

14.
Sensors (Basel) ; 20(6)2020 Mar 23.
Article in English | MEDLINE | ID: mdl-32210147

ABSTRACT

Interstory drift is an important engineering parameter in building design and building structural health monitoring. However, many problems exist in current interstory drift monitoring methods. The traditional method is imprecise-double numerical integration of acceleration data-and other direct monitoring methods need professional equipment. This paper proposes a method to solve these problems by monitoring the interstory drift with a smartphone and a laser device. In this method, a laser device is installed on the ceiling while a smartphone is fixed on a steel projection plate on the floor. Compared with a reference sensor, the method designed in this study shows that a smartphone is competent in monitoring the interstory drift. This method utilizes a smartphone application (APP) named D-Viewer to implement monitoring and data storage just in one place, which is also inexpensive. The results showed that this method has an average percent error of 3.37%, with a standard deviation of 2.67%. With the popularization of the smartphone, this method is promising in acquiring large amounts of data, which will be significant for building assessment after an earthquake.

15.
Int J Mol Sci ; 21(9)2020 May 08.
Article in English | MEDLINE | ID: mdl-32397215

ABSTRACT

Water deficit caused by osmotic stress and drought limits crop yield and tree growth worldwide. Screening and identifying candidate genes from stress-resistant species are a genetic engineering strategy to increase drought resistance. In this study, an increased concentration of mannitol resulted in elevated expression of thioredoxin f (KcTrxf) in the nonsecretor mangrove species Kandelia candel. By means of amino acid sequence and phylogenetic analysis, the mangrove Trx was classified as an f-type thioredoxin. Subcellular localization showed that KcTrxf localizes to chloroplasts. Enzymatic activity characterization revealed that KcTrxf recombinant protein possesses the disulfide reductase function. KcTrxf overexpression contributes to osmotic and drought tolerance in tobacco in terms of fresh weight, root length, malondialdehyde (MDA) content, and hydrogen peroxide (H2O2) production. KcTrxf was shown to reduce the stomatal aperture by enhancing K+ efflux in guard cells, which increased the water-retaining capacity in leaves under drought conditions. Notably, the abscisic acid (ABA) sensitivity was increased in KcTrxf-transgenic tobacco, which benefits plants exposed to drought by reducing water loss by promoting stomatal closure. KcTrxf-transgenic plants limited drought-induced H2O2 in leaves, which could reduce lipid peroxidation and retain the membrane integrity. Additionally, glutathione (GSH) contributing to reactive oxygen species (ROS) scavenging and transgenic plants are more efficient at regenerating GSH from oxidized glutathione (GSSG) under conditions of drought stress. Notably, KcTrxf-transgenic plants had increased glucose and fructose contents under drought stress conditions, presumably resulting from KcTrxf-promoted starch degradation under water stress. We conclude that KcTrxf contributes to drought tolerance by increasing the water status, by enhancing osmotic adjustment, and by maintaining ROS homeostasis in transgene plants.


Subject(s)
Adaptation, Physiological/drug effects , Chloroplast Thioredoxins/genetics , Chloroplast Thioredoxins/metabolism , Gene Expression Regulation, Plant/drug effects , Nicotiana/metabolism , Rhizophoraceae/chemistry , Abscisic Acid/metabolism , Abscisic Acid/pharmacology , Amino Acid Sequence , Droughts , Fructose/metabolism , Glucose/metabolism , Glutathione/metabolism , Hydrogen Peroxide/metabolism , Malondialdehyde/metabolism , Mannitol/toxicity , NADH, NADPH Oxidoreductases/metabolism , Osmotic Pressure , Phylogeny , Plant Leaves/drug effects , Plant Leaves/metabolism , Plant Stomata/cytology , Plant Stomata/metabolism , Plants, Genetically Modified/metabolism , Sequence Analysis , Nicotiana/drug effects , Up-Regulation , Water/metabolism
16.
Gynecol Oncol ; 152(1): 157-165, 2019 01.
Article in English | MEDLINE | ID: mdl-30414739

ABSTRACT

OBJECTIVE: Poly(ADP-ribose) polymerase inhibitors (PARPi) are active in cancer cells that have impaired repair of DNA by the homologous recombination (HR) pathway. Strategies that disrupt HR may sensitize HR-proficient tumors to PARP inhibition. As a component of the core cell cycle machinery, cyclin D1 has unexpected function in DNA repair, suggesting that targeting cyclin D1 may represent a plausible strategy for expanding the utility of PARPi in ovarian cancer. METHODS: BRCA1 wildtype ovarian cancer cells (A2780 and SKOV3) were treated with a combination of CCND1 siRNA and olaparib in vitro. Cell viability was assessed by MTT. The effects of the combined treatment on DNA damage repair and cell cycle progression were examined to dissect molecular mechanisms. In vivo studies were performed in an orthotopic ovarian cancer mouse model. Animals were treated with a combination of lentivirus-mediated CCND1 shRNA and olaparib or olaparib plus scrambled shRNA. Molecular downstream effects were examined by immunohistochemistry. RESULTS: Silencing of cyclin D1 sensitized ovarian cancer cells to olaparib through interfering with RAD51 accumulation and inducing cell cycle G0/G1 arrest. Treatment of lentivirus-mediated CCND1-shRNA in nude mice statistically significantly augmented the olaparib response (mean tumor weight ±â€¯SD, CCND1-shRNA plus olaparib vs scrambled shRNA plus olaparib: 0.172 ±â€¯0.070 g vs 0.324 ±â€¯0.044 g, P< 0.05). CONCLUSIONS: Silencing of cyclin D1 combined with olaparib may lead to substantial benefit for ovarian cancer management by mimicking a BRCAness phenotype, and induction of G0/G1 cell cycle arrest.


Subject(s)
Cyclin D1/physiology , DNA Breaks, Double-Stranded , DNA Repair , Genes, BRCA1 , Ovarian Neoplasms/drug therapy , Phthalazines/therapeutic use , Piperazines/therapeutic use , Animals , Cell Cycle , Cell Line, Tumor , Cyclin D1/genetics , Female , Humans , Mice , Mice, Inbred BALB C , Ovarian Neoplasms/genetics , Ovarian Neoplasms/pathology , Rad51 Recombinase/analysis
17.
Cochrane Database Syst Rev ; 3: CD008018, 2019 03 03.
Article in English | MEDLINE | ID: mdl-30827035

ABSTRACT

BACKGROUND: This is an update of the original review published in the Cochrane Database of Systematic Reviews 2011, Issue 11, and updated in 2015, Issue 4.Chemotherapy has significantly improved prognosis for women with malignant and some non-malignant conditions. This treatment, however, is associated with ovarian toxicity. The use of gonadotropin-releasing hormone (GnRH) analogues, both agonists and antagonists, may have a protective effect on the ovaries. The primary mechanism of action of GnRH analogues is to suppress the gonadotropin levels to simulate pre-pubertal hormonal milieu and subsequently prevent primordial follicles from maturation and therefore decrease the number of follicles that are more vulnerable to chemotherapy. OBJECTIVES: To assess the efficacy and safety of GnRH analogues given before or in parallel to chemotherapy to prevent chemotherapy-related ovarian damage in premenopausal women with malignant or non-malignant conditions. SEARCH METHODS: The search was run for the original review in July 2011, and for the first update in July 2014. For this update we searched the following databases in November 2018: the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, and the Chinese Biomedicine Database (CBM). SELECTION CRITERIA: Randomised controlled trials (RCTs), in all languages, which examined the effect of GnRH analogues for chemotherapy-induced ovarian failure in premenopausal women, were eligible for inclusion in the review. DATA COLLECTION AND ANALYSIS: Two review authors independently extracted data and assessed trial quality using the Cochrane 'Risk of bias' tool. We analysed binary data using risk ratios (RRs) with 95% confidence intervals (CI) and for continuous data, we used the standardized mean difference (SMD) to combine trials. We applied the random-effects model in our analyses. We used the GRADE approach to produce a 'Summary of findings' table for our main outcomes of interest. MAIN RESULTS: We included 12 RCTs involving 1369 women between the ages of 12 and 51.1 years. Participants were diagnosed with breast malignancy, ovarian malignancy, or Hodgkin's lymphoma, and most of them received alkylating, or platinum complexes, based chemotherapy. The included studies were funded by a university (n = 1), research centres (n = 4), and pharmaceutical companies (n = 1). Trials were at high or unclear risk of bias.Comparison 1: GnRH agonist plus chemotherapy versus chemotherapy aloneThe incidence of menstruation recovery or maintenance was 178 of 239 (74.5%) in the GnRH agonist group and 110 of 221 (50.0%) in the control group during a follow-up period no longer than 12 months (RR 1.60, 95% CI 1.14 to 2.24; 5 studies, 460 participants; I2 = 79%; low-certainty evidence), with an overall effect favouring treatment with GnRH agonist (P = 0.006). However, we observed no difference during a follow-up period longer than 12 months between these two groups (P = 0.24). In the GnRH agonist group, 326 of 447 participants had menstruation recovery or maintenance (72.9%) in comparison to the control group, in which 276 of 422 participants had menstruation recovery or maintenance (65.4%) during a follow-up period longer than 12 months (RR 1.08, 95% CI 0.95 to 1.22; 8 studies, 869 participants; I2 = 56%; low-certainty evidence).The incidence of premature ovarian failure was 43 of 401 (10.7%) in the GnRH agonist group and 96 of 379 (25.3%) in the control group (RR 0.44, 95% CI 0.31 to 0.61; 4 studies, 780 participants; I2 = 0%; moderate-certainty evidence), with an overall effect favouring treatment with GnRH agonist (P < 0.00001).The incidence of pregnancy was 32 of 356 (9.0%) in the GnRH agonist group and 22 of 347 (6.3%) in the control group (RR 1.59, 95% CI 0.93 to 2.70; 7 studies, 703 participants; I2 = 0%; low-certainty evidence), with no difference between groups (P = 0.09). However, we are cautious about this conclusion because there were insufficient data about whether the participants intended to become pregnant.The incidence of ovulation was 29 of 47 (61.7%) in the GnRH agonist group and 12 of 48 (25.0%) in the control group (RR 2.47, 95% CI 1.43 to 4.26; 2 studies, 95 participants; I2 = 0%; low-certainty evidence) with an overall effect favouring treatment with GnRH (P = 0.001).The most common adverse effects of GnRH analogues included hot flushes, vaginal dryness, urogenital symptoms, and mood swings. The pooled analysis of safety data showed no difference in adverse effects between GnRH agonist group and control group.Comparison 2: GnRH agonist-antagonist cotreatment plus chemotherapy versus chemotherapy aloneOnly one RCT discussed GnRH agonist-antagonist cotreatment. The limited evidence showed the incidence of menstruation recovery or maintenance was 20 of 25 (80%) in both cotreatment group and control group during a 12-month follow-up period (RR 1.00, 95% CI 0.76 to 1.32; 50 participants; very low-certainty evidence), with no difference between groups (P = 1.00). In the cotreatment group, 13 of 25 participants had menstruation recovery or maintenance (52.0%) in comparison to the control group, in which 14 of 25 participants had menstruation recovery or maintenance (56.0%) during a follow-up period longer than 12 months (RR 0.93, 95% CI 0.56 to 1.55; 50 participants; very low-certainty evidence), with no difference between groups (P = 0.78). The incidence of pregnancy was 1 of 25 (4.0%) in the cotreatment group and 0 of 25 (0%) in the control group (RR 3.00, 95% CI 0.13 to 70.30; 50 participants; very low-certainty evidence), with no difference between groups (P = 0.49). AUTHORS' CONCLUSIONS: GnRH agonist appears to be effective in protecting the ovaries during chemotherapy, in terms of maintenance and resumption of menstruation, treatment-related premature ovarian failure and ovulation. Evidence for protection of fertility was insufficient and needs further investigation. Evidence was also insufficient to assess the effect of GnRH agonist and GnRH antagonist cotreatment on ovarian protection against chemotherapy. The included studies differed in some important aspects of design, and most of these studies had no age-determined subgroup analysis. Large and well-designed RCTs with longer follow-up duration should be conducted to clarify the effects of GnRH analogues in preventing chemotherapy-induced ovarian failure, especially on different age groups or different chemotherapy regimens. Furthermore, studies should address the effects on pregnancy rates and anti-tumour therapy.


Subject(s)
Gonadotropin-Releasing Hormone/analogs & derivatives , Menstruation/drug effects , Premenopause , Primary Ovarian Insufficiency/prevention & control , Administration, Intranasal , Adolescent , Adult , Antineoplastic Agents/adverse effects , Child , Female , Gonadotropin-Releasing Hormone/agonists , Humans , Injections, Intramuscular , Injections, Subcutaneous , Middle Aged , Ovulation/drug effects , Pregnancy , Pregnancy Rate , Primary Ovarian Insufficiency/chemically induced , Randomized Controlled Trials as Topic , Recovery of Function/drug effects , Young Adult
18.
J Obstet Gynaecol Res ; 45(9): 1932-1935, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31282033

ABSTRACT

Splenic pregnancy is a rare form of ectopic pregnancy, with only 21 cases reported in PubMed since 1970. Here we report the case of a healthy 28-year-old woman with splenic pregnancy who complained of menolipsis lasting 56 days and left upper quadrant pain lasting 30 days. The level of ß-human chorionic gonadotropin in serum was 8399 mIU/mL, and transvaginal ultrasonography showed the uterine cavity to be empty without signs of adnexal mass. Subsequent abdominal ultrasonography detected a hyperechoic mass below the spleen containing an anechoic mass measuring 2.6 × 1.2 × 1.6 cm. Laparoscopy detected a gestational mass measuring 6.0 × 4.0 × 3.0 cm on the lower border of the spleen. Pregnancy tissues and a clot were removed under laparoscopic guidance, and the spleen was preserved. Our case suggests that removal of chorionic villi tissue, although not a standard procedure, may be effective for treating splenic pregnancy.


Subject(s)
Abortion, Therapeutic/methods , Laparoscopy/methods , Organ Sparing Treatments/methods , Pregnancy, Abdominal/surgery , Spleen/surgery , Adult , Female , Humans , Pregnancy
19.
Sensors (Basel) ; 19(3)2019 Feb 12.
Article in English | MEDLINE | ID: mdl-30759851

ABSTRACT

Smartphones which are built into the suite of sensors, network transmission, data storage, and embedded processing capabilities provide a wide range of response measurement opportunities for structural health monitoring (SHM). The objective of this work was to evaluate and validate the use of smartphones for monitoring damage states in a three-dimensional (3D) steel frame structure subjected to shaking table earthquake excitation. The steel frame is a single-layer structure with four viscous dampers mounted at the beam-column joints to simulate different damage states at their respective locations. The structural acceleration and displacement responses of undamaged and damaged frames were obtained simultaneously by using smartphones and conventional sensors, while the collected response data were compared. Since smartphones can be used to monitor 3D acceleration in a given space and biaxial displacement in a given plane, the acceleration and displacement responses of the Y-axis of the model structure were obtained. Wavelet packet decomposition and relative wavelet entropy (RWE) were employed to analyze the acceleration data to detect damage. The results show that the acceleration responses that were monitored by the smartphones are well matched with the traditional sensors and the errors are generally within 5%. The comparison of the displacement acquired by smartphones and laser displacement sensors is basically good, and error analysis shows that smartphones with a displacement response sampling rate of 30 Hz are more suitable for monitoring structures with low natural frequencies. The damage detection using two kinds of sensors are relatively good. However, the asymmetry of the structure's spatial stiffness will lead to greater RWE value errors being obtained from the smartphones monitoring data.

20.
Eur J Contracept Reprod Health Care ; 24(1): 54-60, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30656978

ABSTRACT

OBJECTIVE: Premarital sexual practices and contraceptive prevalence rate (CPR) among unmarried women in China remain unclear. We conducted a systematic review and meta-analysis to estimate CPR and analyse contraceptive methods used by unmarried women between 1982 and 2017. METHODS: Wanfang, The China National Knowledge Infrastructure Database, MEDLINE, PubMed and Web of Science were systematically searched. Data on CPR and use of major contraceptive methods were extracted and pooled using a DerSimonian-Laird random effects model. RESULTS: Of 188 articles retrieved from five databases, 22 studies met our inclusion criteria. Overall CPR based on a random effects meta-analysis was 32.2% (95% confidence interval [CI] 24.7%, 39.8%). Pooled rates of contraceptive use were 61.4% (95% CI 47.9%, 74.9%) for condoms, 25.9% (95% CI 14.5%, 37.4%) for pills, 19.8% (95% CI 8.9%, 30.8%) for the rhythm method and 25.4% (95% CI 14.2%, 36.7%) for the withdrawal method. CONCLUSIONS: The sexual and reproductive health situation of unmarried women in China seems to have improved little since the 1990s. Our findings may help to optimise reproductive health care programmes and thereby reduce the alarming rates of unplanned pregnancies and abortions among unmarried women in China.


Subject(s)
Contraception Behavior/trends , Contraception/trends , Sexual Behavior/statistics & numerical data , Single Person/statistics & numerical data , Adolescent , Adult , China/epidemiology , Databases, Factual , Female , Humans , Pregnancy , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL